Tag: CLEAR study
Late-window thrombectomy produces similar outcomes across patients with unwitnessed versus witnessed...
Late-window mechanical thrombectomy appears to lead to “at least the same likelihood” of favourable clinical outcomes in unwitnessed versus witnessed large vessel occlusion (LVO)...
Vesalio announces presentation of positive CLEAR study results at ESMINT 2023
Vesalio has announced the recent presentation of key findings from the CLEAR study—a prospective, multicentre, open-label, single-arm, US Food and Drug Administration (FDA)-regulated investigational...
Vesalio announces completion of enrolment in acute ischaemic stroke IDE study
Vesalio has announced the completion of patient enrolment for the CLEAR US Food and Drug Administration (FDA) investigational device exemption (IDE) study utilising the NeVa...
